April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
April 8, 2024 Robotaxi Revolution: Hype or Reality?
Apple’s Technical Climb To $240 By Year-End
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
BridgeBio Pharma (BBIO) Stock Forecast for 2024–2028. Sell or Buy?
Updated: April 9, 2024 (10:19)
Sector: HealthcareThe share price of BridgeBio Pharma, Inc. (BBIO) now
50/200 Day Moving Average: $31.37 / $30.45
This figure corresponds to the Average Price over the previous 50/200 days. For BridgeBio Pharma stocks, the 50-day moving average is the resistance level today.
For BridgeBio Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in BridgeBio Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BridgeBio Pharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one BridgeBio Pharma share be worth in 2024 - 2028?
When should I take profit in BridgeBio Pharma stock? When should I record a loss on BridgeBio Pharma stock? What are analysts' forecasts for BridgeBio Pharma stock? What is the future of BridgeBio Pharma stock? We forecast BridgeBio Pharma stock performance using neural networks based on historical data on BridgeBio Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BridgeBio Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BridgeBio Pharma shares. This happens once a day.
Historical and forecast chart of BridgeBio Pharma stock
The chart below shows the historical price of BridgeBio Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BridgeBio Pharma stock price can be found in the table below.
Long-term forecasts by years.
BridgeBio Pharma, Inc. is engaged in the discovery, development and supply of various drugs for genetic diseases. The company has a portfolio of 20 development programs that include candidate products from early discovery to late development.
BridgeBio Pharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr 11 | 28.37 | 27.77 | 28.59 | 2.95 |
| Apr 12 | 27.89 | 27.16 | 28.27 | 4.10 |
| Apr 13 | 27.78 | 26.98 | 28.09 | 4.11 |
| Apr 14 | 26.79 | 26.27 | 26.99 | 2.72 |
| Apr 15 | 27.49 | 26.71 | 28.17 | 5.48 |
| Apr 16 | 27.12 | 26.71 | 27.76 | 3.94 |
| Apr 17 | 27.53 | 27.26 | 28.32 | 3.89 |
| Apr 18 | 27.66 | 27.12 | 28.29 | 4.34 |
| Apr 19 | 27.26 | 26.67 | 27.50 | 3.14 |
| Apr 20 | 26.35 | 26.04 | 27.11 | 4.12 |
| Apr 21 | 26.53 | 25.85 | 27.03 | 4.56 |
| Apr 22 | 26.64 | 26.23 | 27.23 | 3.79 |
| Apr 23 | 27.44 | 27.17 | 27.81 | 2.35 |
| Apr 24 | 28.29 | 27.94 | 28.99 | 3.75 |
| Apr 25 | 28.58 | 27.87 | 29.07 | 4.29 |
| Apr 26 | 28.79 | 28.57 | 29.61 | 3.65 |
| Apr 27 | 28.89 | 28.54 | 29.18 | 2.25 |
| Apr 28 | 29.31 | 28.58 | 29.53 | 3.34 |
| Apr 29 | 29.19 | 28.62 | 29.71 | 3.81 |
| Apr 30 | 29.10 | 28.81 | 29.50 | 2.39 |
| May 01 | 29.30 | 28.95 | 29.80 | 2.96 |
| May 02 | 28.72 | 28.03 | 28.95 | 3.30 |
| May 03 | 28.27 | 28.05 | 28.71 | 2.35 |
| May 04 | 28.23 | 27.89 | 28.55 | 2.40 |
| May 05 | 29.00 | 28.60 | 29.77 | 4.09 |
| May 06 | 29.08 | 28.49 | 29.43 | 3.32 |
| May 07 | 28.16 | 27.61 | 28.42 | 2.94 |
| May 08 | 27.33 | 26.54 | 27.77 | 4.61 |
| May 09 | 27.59 | 26.90 | 28.28 | 5.12 |
| May 10 | 27.13 | 26.58 | 27.76 | 4.42 |
BridgeBio Pharma Daily Price Targets
BridgeBio Pharma Stock Forecast 04-11-2024.
Forecast target price for 04-11-2024: $28.37.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.864%.
Pessimistic target level: 27.77
Optimistic target level: 28.59
BridgeBio Pharma Stock Forecast 04-12-2024.
Forecast target price for 04-12-2024: $27.89.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.942%.
Pessimistic target level: 27.16
Optimistic target level: 28.27
BridgeBio Pharma Stock Forecast 04-13-2024.
Forecast target price for 04-13-2024: $27.78.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.951%.
Pessimistic target level: 26.98
Optimistic target level: 28.09
BridgeBio Pharma Stock Forecast 04-14-2024.
Forecast target price for 04-14-2024: $26.79.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.644%.
Pessimistic target level: 26.27
Optimistic target level: 26.99
BridgeBio Pharma Stock Forecast 04-15-2024.
Forecast target price for 04-15-2024: $27.49.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 5.199%.
Pessimistic target level: 26.71
Optimistic target level: 28.17
BridgeBio Pharma Stock Forecast 04-16-2024.
Forecast target price for 04-16-2024: $27.12.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.795%.
Pessimistic target level: 26.71
Optimistic target level: 27.76
BBIO (BBIO) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 27.18 | 26.05 | 29.16 | 10.66 |
| Jun. | 28.84 | 26.51 | 29.85 | 11.18 |
| Jul. | 29.81 | 27.37 | 30.78 | 11.08 |
| Aug. | 27.29 | 26.55 | 28.07 | 5.43 |
| Sep. | 26.97 | 25.57 | 29.18 | 12.38 |
| Oct. | 29.08 | 28.17 | 30.21 | 6.76 |
| Nov. | 31.31 | 30.41 | 32.24 | 5.68 |
| Dec. | 31.59 | 30.69 | 34.30 | 10.54 |
BridgeBio Pharma forecast for this year
BridgeBio Pharma Stock Prediction for May 2024
An uptrend is forecast for this month with an optimal target price of $27.177. Pessimistic: $26.05. Optimistic: $29.16
BridgeBio Pharma Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $28.8376. Pessimistic: $26.51. Optimistic: $29.85
BridgeBio Pharma Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $29.8123. Pessimistic: $27.37. Optimistic: $30.78
BridgeBio Pharma Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $27.2931. Pessimistic: $26.55. Optimistic: $28.07
BridgeBio Pharma Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $26.9738. Pessimistic: $25.57. Optimistic: $29.18
BridgeBio Pharma Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $29.0778. Pessimistic: $28.17. Optimistic: $30.21
BridgeBio Pharma Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $31.308. Pessimistic: $30.41. Optimistic: $32.24
BridgeBio Pharma Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $31.5929. Pessimistic: $30.69. Optimistic: $34.30
BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 30.36 | 27.32 | 32.22 | 15.19 |
| Feb | 28.70 | 26.61 | 30.31 | 12.19 |
| Mar | 25.57 | 23.71 | 27.53 | 13.88 |
| Apr | 22.48 | 20.26 | 24.55 | 17.50 |
| May | 24.64 | 22.08 | 26.69 | 17.28 |
| Jun | 25.38 | 24.32 | 27.26 | 10.77 |
| Jul | 25.57 | 23.01 | 27.94 | 17.61 |
| Aug | 25.34 | 23.79 | 26.40 | 9.86 |
| Sep | 25.37 | 23.56 | 27.52 | 14.38 |
| Oct | 23.89 | 22.21 | 24.70 | 10.06 |
| Nov | 26.69 | 24.85 | 27.48 | 9.59 |
| Dec | 24.01 | 22.80 | 25.23 | 9.65 |
BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 23.86 | 21.38 | 25.32 | 15.56 |
| Feb | 24.32 | 22.93 | 26.60 | 13.79 |
| Mar | 21.92 | 20.27 | 23.12 | 12.33 |
| Apr | 24.31 | 23.27 | 25.55 | 8.91 |
| May | 25.74 | 24.13 | 27.14 | 11.09 |
| Jun | 24.97 | 23.38 | 27.21 | 14.08 |
| Jul | 23.70 | 23.08 | 24.59 | 6.14 |
| Aug | 22.16 | 19.94 | 23.43 | 14.88 |
| Sep | 19.88 | 18.15 | 21.20 | 14.39 |
| Oct | 20.38 | 19.26 | 20.93 | 7.97 |
| Nov | 17.75 | 16.81 | 18.84 | 10.78 |
| Dec | 18.47 | 17.48 | 19.02 | 8.08 |
BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 17.92 | 17.29 | 18.92 | 8.62 |
| Feb | 16.92 | 15.20 | 17.68 | 14.05 |
| Mar | 17.71 | 17.06 | 18.33 | 6.91 |
| Apr | 18.37 | 16.49 | 19.74 | 16.46 |
| May | 18.61 | 18.13 | 20.28 | 10.62 |
| Jun | 18.13 | 17.59 | 18.88 | 6.86 |
| Jul | 17.12 | 15.40 | 18.38 | 16.22 |
| Aug | 16.58 | 14.97 | 17.44 | 14.21 |
| Sep | 16.75 | 16.10 | 17.19 | 6.34 |
| Oct | 17.49 | 17.04 | 18.31 | 6.95 |
| Nov | 17.79 | 16.31 | 19.32 | 15.56 |
| Dec | 18.11 | 17.53 | 19.41 | 9.71 |
BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 20.07 | 18.09 | 21.37 | 15.38 |
| Feb | 19.65 | 19.11 | 20.52 | 6.85 |
| Mar | 19.22 | 18.12 | 19.82 | 8.57 |
| Apr | 20.42 | 19.62 | 22.43 | 12.54 |
| May | 21.08 | 19.08 | 21.96 | 13.10 |
| Jun | 22.07 | 21.03 | 22.98 | 8.49 |
| Jul | 24.82 | 22.88 | 26.01 | 12.03 |
| Aug | 22.24 | 21.17 | 22.85 | 7.34 |
| Sep | 23.19 | 20.78 | 25.30 | 17.87 |
| Oct | 23.55 | 21.96 | 25.51 | 13.92 |
| Nov | 24.69 | 22.92 | 26.10 | 12.17 |
| Dec | 24.75 | 23.14 | 26.75 | 13.47 |
BridgeBio Pharma information and performance
421 KIPLING STREET, PALO ALTO, CA, US
Market capitalization of the BridgeBio Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BBIO shares in the company outstanding by the market price of one share.
EBITDA of BridgeBio Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
